Asherman's Syndrome Treatment in India: Restoring Fertility

About 1 in 5 women develops Asherman’s syndrome after a uterine procedure. A D&C (dilation and curettage) is the most common trigger. Asherman’s syndrome is a condition where scar tissue forms inside the uterus. This blocks the uterine cavity and disrupts periods and fertility. For many women, the first question after diagnosis is: Can Asherman’s syndrome cause weight gain?

The short answer is no. Asherman’s syndrome does not directly cause weight gain. But knowing why weight changes can happen alongside this condition — and what good treatment looks like — matters a great deal for your recovery and your family plans.

This guide explains what Asherman’s syndrome is and how it is diagnosed. It covers how hysteroscopic adhesiolysis (the surgical removal of uterine scar tissue) is performed at leading hospitals in India. It also shows what fertility outcomes look like after treatment. And it explains how patients from Australia, the UK, and Nigeria get high-quality care at 70–90% less than private clinic prices at home.

What Is Asherman’s Syndrome? (Also Called Asherman Disease)

Asherman’s syndrome — also called Asherman disease or intrauterine adhesions — is a condition where scar tissue (adhesions) forms inside the uterine cavity. This scar tissue can partly or fully block the cavity. Dr. Joseph Asherman, an Israeli gynaecologist, first described it in 1948. It remains one of the leading causes of secondary infertility and menstrual problems in women of reproductive age worldwide.

What Causes Asherman’s Syndrome?

Over 95% of Asherman’s syndrome cases are linked to trauma to the uterine lining (endometrium). This trauma almost always comes from surgical procedures on a pregnant or recently pregnant uterus (WHRIA, 2024). The most common trigger is a D&C — especially after a miscarriage, incomplete abortion, or retained placental fragments after delivery.

Studies show Asherman’s syndrome develops in 2–48% of women after surgical removal of an early pregnancy loss. The risk rises sharply when multiple procedures are done or when sharp curettage is used (Journal of Obstetrics and Gynaecology Canada, 2016).

Other causes include:

• Myomectomy (surgical removal of uterine fibroids)

• C-section complications or uterine repair surgery

• Severe uterine infections such as endometritis

• Radiation therapy directed at the pelvis

The Classic Triad of Asherman Syndrome Symptoms

Asherman syndrome is known by three connected symptoms. Doctors call this the Asherman triad:

• Amenorrhoea or hypomenorrhoea — absent or dramatically reduced menstrual flow, even though your hormone levels are normal. This happens because the scar tissue blocks menstrual blood from exiting the uterus.

• Cyclical pelvic pain — you may still feel the cramping of a menstrual cycle, but blood builds up behind the adhesions and cannot drain properly. This causes significant discomfort.

• Infertility or recurrent miscarriage — the altered uterine environment prevents embryo implantation or disrupts early pregnancy development. This is often how Asherman’s is first identified in women who had no known uterine procedure risk.

If you notice a sudden drop in period flow after a D&C, miscarriage management, or any uterine surgery, tell your gynaecologist right away. Early diagnosis leads to better treatment outcomes.

Does Asherman’s Syndrome Cause Weight Gain?

No. Asherman’s syndrome does not directly cause weight gain. The adhesions (scar tissue) form inside the uterine cavity. They have no effect on your metabolism, hormones, or fat storage (American Society for Reproductive Medicine).

That said, some women do notice weight changes around the time of diagnosis. These are almost always linked to indirect factors:

• Stress and psychological impact — dealing with infertility, recurrent miscarriage, or absent periods takes a real emotional toll. Chronic stress can alter eating patterns and physical activity levels.

• Post-surgical recovery — in the weeks after a D&C or hysteroscopy, reduced activity temporarily affects your energy balance.

• Co-existing conditions — if your Asherman’s followed a complicated pregnancy or postpartum event, you may also have a thyroid change or other hormonal shift. These are separate from the Asherman’s itself but are worth investigating alongside it.

If you have both menstrual changes and unexplained weight changes, tell your specialist about both. Thyroid function tests and other hormonal markers are worth checking alongside an Asherman’s evaluation.

How Is Asherman’s Syndrome Diagnosed?

Asherman’s syndrome needs a specialist gynaecological assessment to diagnose. A symptom pattern alone is not enough. A definitive diagnosis requires direct visualisation of the uterine cavity.

Hysteroscopy — The Gold Standard Diagnostic Test

Hysteroscopy is a procedure where a thin, lighted camera (hysteroscope) is passed through the cervix into the uterine cavity. It lets the gynaecologist see the adhesions directly — their location, density, and how much of the cavity they affect. It is the only method that confirms the diagnosis with certainty.

The procedure is typically done as a day case under light sedation or local anaesthesia. Leading centres such as Apollo Hospitals Chennai and Fortis Memorial Research Institute, Gurugram, perform over 1,000 hysteroscopic procedures each year — including complex Asherman’s cases referred from Australia, the UK, and Nigeria.

The Royal College of Obstetricians and Gynaecologists (RCOG) recommends hysteroscopy as the definitive investigation when intrauterine adhesions are suspected (RCOG, 2023).

Supporting Diagnostic Tests

Two non-invasive tests are often used when hysteroscopy is not immediately available, or as a first assessment:

• Saline Infusion Sonography (SIS) — an ultrasound where saline solution is gently injected into the uterus to outline the cavity. It can identify filling defects and irregular areas where adhesions may be present.

• Hysterosalpingogram (HSG) — an X-ray using contrast dye that maps the uterine cavity shape and checks whether the fallopian tubes are open. It can suggest but not confirm Asherman’s.

Neither test replaces hysteroscopy. But both can guide whether urgent specialist referral is needed. This is especially useful for Nigerian patients, where advanced diagnostic tools may not always be locally available.

Hysteroscopic Adhesiolysis — The Gold Standard Treatment for Asherman’s Syndrome in India

Hysteroscopic adhesiolysis is the main and most effective treatment for Asherman’s syndrome. It is minimally invasive and safe when performed by an experienced surgeon. It is highly effective — with success rates of 70–90% for restoring normal uterine anatomy in mild-to-moderate cases (multiple peer-reviewed studies, including ACOG clinical guidance, 2020).

What Happens During Adhesiolysis?

During the procedure, your surgeon inserts a hysteroscope through the cervix into the uterine cavity. The surgeon uses small scissors or a bipolar energy instrument to carefully cut and remove the scar tissue. The goal is to restore the uterine cavity to its normal shape. This allows the endometrium (uterine lining) to grow back and function normally.

The procedure takes 30–60 minutes under general or regional anaesthesia. Most patients go home the same day or after one night in the hospital.

In India, leading JCI-accredited hospitals such as Apollo Hospitals (Chennai and Delhi), Max Healthcare (Delhi), and Fortis Memorial Research Institute (Gurugram) employ gynaecologists with FRCS, MCh, and DNB qualifications. These surgeons perform hundreds of adhesiolysis procedures each year. They follow protocols that match private gynaecology centres in Sydney or London — at a fraction of the cost.

Post-Operative Care and Preventing Recurrence

Post-operative care is just as important as the surgery itself. After your adhesiolysis, your medical team in India will typically:

• Insert a small intrauterine balloon for 5–7 days to keep the uterine walls separated while healing begins

• Prescribe a course of oestrogen therapy — sometimes combined with progestins — to encourage healthy endometrial regrowth and reduce the chance of new adhesions forming

• Apply an anti-adhesion gel or barrier directly inside the uterus during surgery as an extra layer of protection

• Schedule a follow-up hysteroscopy 4–6 weeks after your procedure to check for any new adhesion formation

Post-operative hormonal therapy has been shown to reduce Asherman’s recurrence rates from an average of 15–20% down to below 5–10% for mild-to-moderate cases (WHO, 2021). With the right post-op care, most patients do not need a second procedure.

Can You Get Pregnant After Asherman’s Syndrome? What to Expect

Yes, many women can become pregnant after treatment for Asherman’s syndrome. Live birth rates following successful adhesiolysis are 70-80% in those with mild-to-moderate adhesions (ACOG, 2020). Rates are lower in severe cases but can be further optimised with IVF after adhesiolysis.

Fertility Outcomes After Adhesiolysis

Your fertility outcomes depend on three key factors:

• Severity of adhesions before treatment — mild and moderate cases respond best to a single adhesiolysis procedure. Severe cases may require two or three procedures over 12–18 months.

• Surgeon experience — specialists performing 200+ hysteroscopies annually consistently achieve better cavity restoration and lower recurrence rates.

• Post-operative compliance — completing the full hormonal therapy course and attending all follow-up appointments is critical for sustained success.

Amaka, a 33-year-old woman living in Lagos, was found to be suffering from moderate Asherman’s syndrome due to two D&Cs carried out post a miscarriage. She was able to conceive naturally nine months after undergoing hysteroscopic adhesiolysis surgery in an accredited Delhi hospital through Divinheal. “They were very meticulous about the whole process, and I felt really well taken care of. It cost less than one appointment would have done in a London private hospital,” Amaka added.

Illustrative composite based on typical patient journeys. Name changed for privacy.

Pregnancy Risks to Monitor After Asherman’s Syndrome

Even after successful treatment, pregnancies after Asherman’s syndrome carry an elevated risk profile that needs close obstetric monitoring. These risks include:

• Higher likelihood of first-trimester miscarriage

• Preterm labour and delivery

• Abnormal placental implantation — placenta previa (placenta positioned over the cervix) or placenta accreta (placenta growing into the uterine wall)

• Postpartum haemorrhage (heavy bleeding after delivery)

Your medical team in India will advise a waiting period of 6–12 months after adhesiolysis before trying to conceive. This gives the uterine lining time to stabilise. Once pregnant, close monitoring from early in the first trimester is essential. Your Indian hospital will provide a full discharge summary and follow-up plan for your obstetrician at home.

Asherman’s Syndrome Treatment Cost: India vs Australia, Nigeria & the UK

Treating Asherman’s syndrome in India costs between ₹1,50,000 and ₹3,50,000 (approximately USD 1,800–4,200). At leading JCI-accredited hospitals, this typically includes the surgeon’s fee, anaesthesia, a 2–3 night hospital stay, pre-operative investigations, and post-operative consultations. Some packages also include airport transfer and accommodation coordination.

All figures are indicative only. Cost may vary depending upon the class of hospital, seniority of the surgeon, and difficulty level of the surgery. 

Divinheal will provide you with an individual quote.

Why Australian and UK Patients Choose India

Australian Medicare waiting time for non-emergency gynaecological surgery is 6-12 months (Medicare statistics, 2023). Private adhesiolysis treatment in Sydney or Melbourne will cost AUD 15,000-25,000 — an expensive procedure even on a private health insurance plan. An Indian option helps Australian patients save 75-90% of costs and get treated within 2-4 weeks of inquiry.

UK patients face NHS wait-lists of 3–6 months for elective hysteroscopy. Private NHS-equivalent care starts at £8,000. Indian hospitals offer the same surgical standards — many surgeons hold FRCS qualifications — at 70–85% less.

Why Nigerian Patients Choose India

For patients in Lagos, Abuja, or Port Harcourt, the challenge is often access as much as cost. Advanced operative hysteroscopy — needed for moderate-to-severe Asherman’s — is not always available at private facilities locally. India provides that access, along with Divinheal’s step-by-step visa application support, flight coordination, and on-ground assistance from arrival to discharge.

Is Medical Travel to India for Asherman’s Syndrome Safe?

Yes — medical travel to India for Asherman’s syndrome treatment is safe. You need to choose an internationally accredited hospital and an experienced gynaecologist. India has over 40 JCI (Joint Commission International)-accredited hospitals. JCI accreditation is the global benchmark for hospital quality and patient safety. It means the facility meets strict international standards across surgical protocols, infection control, and patient care.

What Accreditation Means for You

Indian JCI hospitals are audited externally. For patients originating from Australia and the United Kingdom, this provides the same reassurance that they would receive when choosing a private hospital in their own country. The number of hysteroscopy cases performed each year by Apollo Hospitals Chennai exceeds 2,000, thereby developing their surgical and management skills in handling potential complications. NABH (National Accreditation Board for Hospitals) accreditation provides a parallel domestic quality benchmark.

Indian gynaecologists at these centres often hold postgraduate qualifications from UK or Australian training programmes — FRCS, MRCOG, or DNB. They know the clinical expectations of international patients.

How to Evaluate Hospitals and Reviews

While conducting an online search for hospitals, always try to find reviews that include specific treatments, surgeon names, and actual patients' experiences, rather than the number of stars given to them. It would be important to observe consistencies across several sources, including Google Reviews, health tourism forums, and patient reviews. Pay attention to how hospitals respond to critical feedback. Transparency is a genuine quality signal.

Divinheal pre-vets all partner hospitals before recommending them. Each hospital on the Divinheal network has been assessed for accreditation status, hysteroscopy volume, surgeon credentials, and international patient support.

How Divinheal Supports You Before, During, and After Treatment

Travelling abroad for gynaecological surgery can feel daunting — especially for patients managing this alone, away from their usual support system. Divinheal provides end-to-end coordination so you can focus on your health, not logistics.

Before You Travel

Divinheal assists with visa applications — a top priority for Nigerian patients applying for an Indian medical visa. The team arranges virtual consultations with FRCS or MRCOG-qualified surgeons, so you can ask questions and review your case before booking flights. Flight and accommodation near your treating hospital are coordinated in advance.

Sarah, who lives in Perth, had to go through hysteroscopic adhesiolysis after a few D&Cs following a miscarriage. She felt nervous about travelling alone. “Divinheal set me up with a patient manager before I even booked my flights,” she said. By the time she arrived in Chennai, she already knew her surgeon, her hospital, and what the whole process would look like.

Composite for representation. Name changed for privacy.

During Your Stay

Once you arrive, Divinheal's ground staff will take care of the airport transfer and hospital admission for you. You will have your own patient manager on standby during your stay. Should you require a multilingual interpreter, this can be prearranged for you. Packages for treatment of Asherman's adhesiolysis usually consist of 2-3 days' post operative stay at the hospital, giving you time to recover before moving to your accommodation.

After You Return Home

Divinheal arranges follow-up consultations remotely with your treating physician, normally within two weeks, one month, and three months after the procedure. The GP in Sydney, London, Lagos, or Abuja gets a comprehensive discharge report on your diagnosis, surgery results, medication regimen, and follow-up procedure

Divinheal’s team responds to patient queries within one hour, including after you’ve returned home. Medicare covers local GP visits in Australia, but it does not cover teleconsultations with overseas specialists. Divinheal will clarify any cost implications before you travel.

What Happens After You Return Home? Post-Treatment Care Guide

Managing your recovery after returning home from India needs a clear plan and close communication with both your overseas specialists and your local GP. Here’s what to expect.

The time frame for recovery from Asherman's syndrome before attempting fertility treatments is 6 to 12 months. Over 75% of all patients respond positively in terms of their treatment outcome when provided with follow-ups (several peer-reviewed journals between 2020 and 2023). You may contact your general practitioner for prescriptions related to hormone therapy and referral to a gynaecologist.

Long-Term Outcomes After Asherman’s Syndrome Treatment

With the right treatment and consistent follow-up, most women achieve a good long-term outcome after Asherman’s syndrome adhesiolysis. The three markers of success are:

• Return of a regular menstrual cycle within 2–3 months post-procedure

• No recurrence of adhesions on follow-up hysteroscopy at 4–6 weeks

• Conception within 12–24 months, for women actively trying to conceive

Recurrence Risk and How to Minimise It

Asherman’s syndrome can come back after treatment, especially in severe cases where dense adhesions cover most of the uterine cavity. Recurrence happens when new scar tissue forms during the post-operative healing phase. Immediate post-operative hormonal therapy — combined with an intrauterine balloon or barrier — significantly lowers this risk: from 15–20% down to below 5–10% in mild-to-moderate cases (WHO, 2021).

If the case is mild, treatment usually bumps pregnancy rates up to 70–80%. Miscarriage rates drop compared to women who don’t get treated for Asherman’s, which isn’t just hearsay—several peer-reviewed studies and NICE guidelines back this up. But if the case is severe, it often takes two or three procedures spread out over a year or so to really get the cavity back to normal.

Factors That Influence Long-Term Fertility

Your long-term fertility outcomes after Asherman’s treatment depend mainly on:

• Severity of adhesions before treatment — mild and moderate cases have the best prognosis

• Surgeon experience — specialists performing high volumes of hysteroscopy annually achieve consistently better cavity restoration

• Adherence to post-operative care — hormone therapy and follow-up hysteroscopy are not optional; they directly determine whether the uterus heals cleanly

• Your age and overall reproductive health — younger patients with no other fertility factors typically have the strongest outcomes

India’s leading gynaecology centres offer a level of Asherman’s expertise that matches the best private reproductive surgery units in Sydney, London, or Lagos — at a price that makes treatment accessible rather than out of reach. For many international patients, that difference is life-changing.

Quick Answer — At a Glance
Skim this if you’re short on time.

Asherman’s Syndrome — Key Facts  What it is: Asherman’s syndrome (Asherman disease) is the formation of scar tissue (adhesions) inside the uterus, usually after a D&C procedure, miscarriage management, or uterine surgery Does it cause weight gain: No — Asherman’s syndrome does not directly cause weight gain. The adhesions affect the uterine cavity only, not metabolism or hormones Main symptoms: Absent or very light periods (amenorrhoea/hypomenorrhoea), cyclical pelvic pain, and infertility or recurrent miscarriage — the classic Asherman triad Gold standard treatment: Hysteroscopic adhesiolysis — minimally invasive removal of scar tissue; 70–90% success rate in mild-to-moderate cases India treatment cost: ₹1,50,000 – ₹3,50,000 (USD 1,800–4,200) at JCI-accredited hospitals Savings vs home country: 75–90% less than private clinics in Australia; 70–85% less than private clinics in the UK Pregnancy after treatment: Possible — live birth rates of 70–80% for mild-to-moderate cases after successful adhesiolysis Who Divinheal connects you with: JCI-accredited hospitals in India with FRCS/MCh-qualified gynaecologists, plus full logistics support from visa to discharge